<DOC>
	<DOC>NCT02741960</DOC>
	<brief_summary>This is a multicenter, randomised, double-blind placebo controlled trial on the efficacy and safety of add-on metformin to conventional immunosuppressants in systemic lupus erythematosus (SLE). The purpose of this study is to evaluate: 1) the effect of metformin on reducing disease flares; 2) the influence of metformin on corticosteroid sparing effect; 3) the influence of metformin on body mass index (BMI); 4) the safety of metformin.</brief_summary>
	<brief_title>The Effect of Metformin on Reducing Lupus Flares</brief_title>
	<detailed_description />
	<mesh_term>Lupus Erythematosus, Systemic</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>Willingness of the subject to participate in the study, proven by signing the informed consent; Systemic lupus erythematosus (SLE), as defined by meeting at least 4 of 11 classification criteria of American College of Rheumatology for the classification of systemic lupus erythematosus, either sequentially or coincidentally. The 4 criteria doesn't need to be present at the time of study enrollment; The course of SLE longer than1 year; and there is a clear record of disease flares in the past 1 year with prednisone more than 20mg/day; Patients with mild/moderate disease activity (score≤ 6 at screening on SLEDAI); no British Isles Lupus Assessment Group (BILAG) A or no more than one B; A stable treatment regimen with fixed doses of prednisone (≤ 20mg/day), antimalarial, or immunosuppressive drugs (azathioprine/ mycophenolate mofetil/ methotrexate/ ciclosporin/ leflunomide/ thalidomide) for at least 30 days. Patients who are unwilling to sign the inform consent; Alanine aminotransferase (ALT)/ aspartate aminotransferase (AST) &gt; 2 times upper normal limits; creatinine clearance rate &lt; 60ml/min; Patients who used cyclophosphamide 6months before screening; used biological agents 12months before screening; Previous exposure of metformin within 30 days before screening; or previous history of intolerant to metformin; Patients who diagnosed of diabetes mellitus; Pregnancy or lactation.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>metformin</keyword>
	<keyword>systemic lupus erythematosus</keyword>
</DOC>